AdventHealth offers new, minimally invasive AFib procedure

AdventHealth has launched a new, FDA-approved treatment program for atrial fibrillation patients, according to an Aug. 15 news release. 

Advertisement

The program is specifically for patients who experience longstanding persistent atrial fibrillation — a group that is often medically underserved, David Spurlock, MD, a cardiothoracic surgeon at AdventHealth Orlando stated in the release.

AdventHealth patients with the condition can now elect to undergo a minimally invasive procedure that uses cameras to guide where incisions should be made on the outside of the heart, rather than fully opening the chest to perform the procedure. 

A second procedure is performed later and uses leg veins as a pathway to the heart where surgeons can cauterize necessary areas of the organ. Overall, the two-part procedure leaves an incision of just 2 centimeters and only a one- or two-night stay in the hospital, according to the release.  

“By having both procedures done, one outside the heart and the other inside, it increases the patient’s chance of being able to maintain normal rhythm long term,” Mahmoud Altawil, MD, an electrophysiologist at AdventHealth Orlando stated in the release.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Cardiology

Advertisement